Company Overview - Serina Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing a pipeline of wholly owned drug product candidates aimed at treating neurological diseases and other indications [2] - The company is headquartered in Huntsville, Alabama, on the campus of the HudsonAlpha Institute of Biotechnology [2] Technology and Innovation - Serina's proprietary POZ Platform is designed to enhance the integrated efficacy and safety profile of various therapeutic modalities, including small molecules, RNA-based therapeutics, and antibody-based drug conjugates (ADCs) [2] Upcoming Events - Steve Ledger, the CEO of Serina, is scheduled to present at the JonesResearch Hosts: Virtual CNS Day on April 29, 2025, at 12:00 p.m. EDT [1] - A live webcast of the presentation will be available for registered attendees, with an archived replay accessible for 90 days post-event [1]
Serina Therapeutics to Present at JonesResearch Virtual CNS Day